Lombard Odier Asset Management (USA)’s Accelerate Diagnostics AXDX Stock Holding History

Lombard Odier Asset Management (USA)’s Portfolio AXDX Stock Details AXDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-6,497	Closed	-$747K	–	249
2018 Q4	$747K	Sell	6,497 -7,503	-54%	-$1.11M	0.06%	187
2018 Q3	$3.21M	Hold	14,000	–	–	0.24%	118
2018 Q2	$3.12M	Buy	14,000 +4,000	+40%	+$895K	0.2%	141
2018 Q1	$2.29M	Sell	10,000 -3,009	-23%	-$790K	0.16%	129
2017 Q4	$3.41M	Buy	13,009 +10,509	+420%	+$2.46M	0.26%	108
2017 Q3	$561K	Buy	+2,500	New	+$614K	0.04%	196

Other funds holding AXDX

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Lombard Odier Asset Management (USA)'s AXDX Position: Q1 2019 in Review

Lombard Odier Asset Management (USA) sold out of Accelerate Diagnostics (AXDX) in Q1 2019, closing a stake of 6,497 shares — an estimated $747K sold.

Lombard Odier Asset Management (USA) first reported a position in AXDX in Q3 2017 and held it in 6 quarters. The position peaked at $3.41M in Q4 2017. 114 funds tracked by Wall St. Rank hold AXDX as of Q1 2019.

Lombard Odier Asset Management (USA) reported no remaining Accelerate Diagnostics position as of Q1 2019 after selling out during the quarter.
Lombard Odier Asset Management (USA) sold 6,497 Accelerate Diagnostics shares in Q1 2019, an estimated $747K.
Lombard Odier Asset Management (USA) first reported a position in Accelerate Diagnostics in Q3 2017 and held it in 6 quarters.
Lombard Odier Asset Management (USA)'s Accelerate Diagnostics position peaked at $3.41M in Q4 2017.
114 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q1 2019.

Based on Lombard Odier Asset Management (USA)'s 13F filing for Q1 2019, filed 15 May 2019.